Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway

The development of chemoresistance remains a major challenge that accounts for colorectal cancer (CRC) lethality. Dichloroacetate (DCA) was originally used as a metabolic regulator in the treatment of metabolic diseases; here, DCA was assayed to identify the mechanisms underlying the chemoresistance...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogene
Autors principals: Liang, Yu, Hou, Lidan, Li, Linjing, Li, Lei, Zhu, Liming, Wang, Yu, Huang, Xin, Hou, Yichao, Zhu, Danxi, Zou, Huimin, Gu, Yan, Weng, Xiaoling, Wang, Yingying, Li, Yue, Wu, Tianqi, Yao, Mengfei, Gross, Isabelle, Gaiddon, Christian, Luo, Meng, Wang, Jianhua, Meng, Xiangjun
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6949190/
https://ncbi.nlm.nih.gov/pubmed/31597953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-019-1035-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars